|
Study | Hypertension | Diabetes mellitus | Dyslipidemia | Smoking | Aspirin | CCB | Nitrate | Nicorandil | β-Blockers | ACEIs/ARBs |
|
Kensuke Io et al. | NR |
Sunao Kodama et al. | NR |
Munenori Kosugi et al. | NR |
Akihiro Nakagomi et al. | NR |
Masanobu Ishii et al. | 60 (46.9) vs. 53 (41.4) | 26 (20.3) vs. 21 (16.7) | 121 (94.5) vs. 50 (39.1) | 50 (39.1) vs. 51 (39.8) | 37 (28.9) vs. 35 (27.3) | 122 (95.3) vs. 124 (96.9) | 14 (10.9) vs. 19 (14.8) | 9 (7.0) vs. 9 (7.0) | 8 (6.3) vs. 6 (4.7) | 34 (26.6) vs. 29 (22.7) |
Min Seok Oh et al. | 110 (39.1) vs. 111 (39.5) | 71 (25.4) vs. 73 (26.0) | NR | 89 (31.7) vs. 82 (29.2) | 180 (64.1) vs. 179 (63.7) | 274 (97.5) vs. 274 (97.5) | 108 (38.4) vs. 105 (37.4) | 102 (36.3) vs. 97 (34.5) | NR | 50 (17.8) vs. 49 (17.4) |
Zhe Hao Piao et al. | 122 (41.9) vs. 74 (35.6) | 34 (11.7) vs. 21 (10.1) | 29 (10.0) vs. 11 (5.3) | 156 (53.8) vs. 115 (55.3) | 229 (80.4) vs. 121 (72.0) | 245 (83.9) vs. 169 (80.9) | 191 (65.6) vs. 116 (59.2) | 99 (35.0) vs. 66 (33.7) | 41 (14.0) vs. 17 (8.1) | 139 (47.6) vs. 83 (39.7) |
So Jin Park et al. | 1265 (54.9) vs. 869 (48.4) | 879 (38.2) vs. 617 (34.4) | NR | NR | 2177 (94.5) vs. 1528 (85.1) | 1973 (85.6) vs. 1476 (82.2) | 2072 (89.9) vs. 1547 (86.2) | 1108 (48.1) vs. 740 (41.2) | NR | 895 (38.8) vs. 474 (26.4) |
Won-Woo Seo et al. | 306 (41.1) vs. 296 (32.4) | 73 (9.8) vs. 70 (7.7) | 276 (37.1) vs. 125 (13.7) | NR | 394 (53.0) vs. 239 (26.1) | 701 (94.2) vs. 791 (86.5) | 614 (82.5) vs. 726 (79.4) | NR | 46 (6.2) vs. 59 (6.5) | 168 (22.6) vs. 98 (10.7) |
Hiroyoshi Mori et al. | 101 (47.9) vs. 101 (47.9) | 38 (18.0) vs. 32 (15.2) | 136 (64.5) vs. 137 (64.9) | 134 (63.5) vs. 122 (57.8) | 112 (53.1) vs. 108 (51.2) | 197 (93.4) vs. 203 (96.2) | 99 (46.9) vs. 92 (43.6) | NR | 7 (3.3) vs. 9 (4.3) | 45 (21.3) vs. 57 (27.0) |
|